Intraocular miotics and postoperative inflammation

Area of Science:

• Ophthalmology
• Surgical Research
• Pharmacology

Background:

• Cataract extraction with intraocular lens (IOL) implantation is a common surgical procedure.
• Postoperative inflammation is a potential complication that can affect visual outcomes.
• Pharmacological agents are sometimes used to mitigate inflammation after surgery.

Purpose of the Study:

• To objectively assess and compare the effects of acetylcholine chloride, carbachol, and balanced salt solution (BSS) on postoperative inflammation following extracapsular cataract extraction with IOL implantation.
• To investigate the impact of these agents on the re-establishment of the blood-aqueous barrier.

Main Methods:

• Sixty patients undergoing planned extracapsular cataract extraction with IOL implantation were randomized into three groups.
• Patients received acetylcholine chloride, carbachol, or BSS post-IOL placement and at the end of surgery.
• Postoperative inflammation was objectively measured using a Kowa FC-1000 laser flare and cell meter on postoperative days one and eight.

Main Results:

• The carbachol group exhibited significantly higher levels of both flare and cells on postoperative days one and eight compared to the acetylcholine and BSS groups.
• The acetylcholine group showed significantly less flare than the BSS group on day one, with no significant difference by day eight.
• No significant differences in cell counts were observed between the acetylcholine and BSS groups on either day.

Conclusions:

• Carbachol administration is associated with increased postoperative inflammation after cataract surgery, potentially due to prolonged miosis delaying blood-aqueous barrier recovery.
• Acetylcholine chloride may offer a benefit in reducing early postoperative inflammation compared to BSS.
• Further research is warranted to elucidate the long-term effects and optimal use of miotic agents in ophthalmic surgery.